C2Dx Announces Rebrand to Everis Medical, Marking a New Era of Growth
-
Global film industry reels from Trump tariff announcement
-
Cardinals assemble to elect pope and set course for church
-
Meta content moderator cuts over 2,000 jobs in Spain: union
-
Pakistan conducts second missile test, India readies civil defence drills
-
Pro-EU or pro-Trump? Romania faces decisive choice in vote
-
Nazi surrender site sets the scene for Wim Wenders short film
-
French court backs Olympics choreographer in cyberbullying case
-
Romania run-off pits pro-Trump nationalist against centrist mayor
-
South Africa's Rabada back in IPL after serving drug ban
-
Pride and excitement as UK crowds celebrate 80 years since WWII's end
-
Ex-French interior minister Darmanin apologises for 2022 Champions League fiasco
-
Zhao on brink of becoming China's first World Snooker champion
-
Stars come out for Met Gala, showcasing Black dandyism
-
Jury selection begins in Sean 'Diddy' Combs sex crimes trial
-
Martinez rushing to be ready for Barca showdown, says Inter's Inzaghi
-
Warren Buffett to remain as Berkshire Hathaway board chair
-
UK royals lead celebrations to mark 80 years since WWII end
-
Top Spanish court drops tax complaint against ex-king Juan Carlos
-
Who are the Middle East's Druze religious community?
-
Russian reporter critical of Ukraine war escapes to France
-
France names first Concorde jet a historical monument
-
France, EU take aim at Trump's assault on science, seek to lure US researchers
-
Catholic Church's direction in the balance as vote conclave looms
-
German coalition deal signed on eve of Merz govt launch
-
UK begins four days of events to honour last WWII veterans
-
Cassocks competition: whose outfit will new pope wear?
-
Traditional culture, fancy dress meet at Hong Kong's raucous bun festival
-
Spain foreign tourist numbers break record in early 2025
-
Catholic Church's direction in the balance as conclave looms
-
France, EU leaders take aim at Trump in bid to lure US scientists
-
Olympic 100m medallist Kerley denies battery, admits to 'altercation'
-
Man Utd have 'big responsibility' to win Europa League: Amorim
-
Israel cabinet approves plan for Gaza 'conquest'
-
Alexander-Arnold confirms Liverpool exit after 'hardest decision'
-
Francis's popemobile converted into clinic for Gazan children
-
Spain's blackout highlights renewables' grid challenge
-
Trent Alexander-Arnold announces Liverpool departure
-
Top French chefs warm to AI in the kitchen
-
France, EU leaders spearhead effort to lure US scientists
-
Huthis say US bombed Yemen after strike on Israel's main airport
-
Pakistan conducts second missile test since renewed India standoff
-
Israel cabinet approves plan including Gaza 'conquest'
-
Oil prices slide after OPEC+ output hike
-
Kardashian ready to 'confront' her Paris attackers in court: lawyers
-
Flight club: Pinching pigeons on the India-Pakistan border
-
Trump orders rebuilding and reopening of defunct US prison Alcatraz
-
Jury selection to begin in Sean 'Diddy' Combs sex crimes trial
-
Facing a broken economy, Ghana's tech-savvy teens turn to fraud
-
Trump says ordering '100% tariff' on all movies produced abroad
-
Victorious Australian PM holds 'warm' chat with Trump
NYSE - LSE
| RBGPF | 6.26% | 67.21 | $ | |
| VOD | -0.23% | 9.588 | $ | |
| RYCEF | 0.67% | 10.42 | $ | |
| CMSC | -0.09% | 22.08 | $ | |
| CMSD | 0.04% | 22.329 | $ | |
| SCS | -0.4% | 10.1 | $ | |
| RELX | 0.3% | 55.186 | $ | |
| RIO | -0.29% | 59.53 | $ | |
| BCC | -1.14% | 95.07 | $ | |
| JRI | -0.3% | 13.031 | $ | |
| BCE | -1.19% | 21.197 | $ | |
| GSK | -0.08% | 39.04 | $ | |
| AZN | -0.42% | 72.14 | $ | |
| BP | 2.73% | 28.91 | $ | |
| BTI | 1.3% | 43.74 | $ | |
| NGG | 0.06% | 71.724 | $ |
C2Dx Announces Rebrand to Everis Medical, Marking a New Era of Growth
KALAMAZOO, MI / ACCESS Newswire / May 5, 2025 / C2Dx, a leading medical device company known for acquiring and revitalizing essential, underserved technologies, is proud to announce its rebrand to Everis. This transformation reflects the company's continued commitment to elevating possibilities in healthcare, expanding its focus, and propelling impactful surgical technologies forward.
Founded in 2019 by industry experts, C2Dx was built on the belief that proven medical devices still have untapped potential to serve patients and providers. Now, as Everis, the company embraces a name that evokes endurance (ever), progress (evolving), and energy (life force)-capturing the spirit of continuous innovation and purpose-driven growth.
"Everis represents who we are becoming," said Sarah Hollingsworth, Vice President of Marketing. "We're not only preserving the legacy of essential technologies-we're building their future. Our new identity reflects our mission to redefine what's possible in patient care."
While the name is new, the company's dedication remains unchanged: providing exceptional customer support, trusted solutions, and a relentless focus on enhancing outcomes.
"Our evolution into Everis reflects more than a name change-it's a signal of our long-term growth trajectory," said Kevin McLeod, CEO. "We're actively building a portfolio of transformative technologies, and we see corporate development as a vital path to scale our impact. Whether through strategic partnerships or acquisitions, we're focused on expansion and growth."
Everis will debut its new branding at COSM 2025, inviting physicians to experience what's next.
For more information, visit everismedical.com.
Media Contact:
Sarah Hollingsworth
Vice President of Marketing
Everis Medical
[email protected]
everismedical.com
SOURCE: Everis
View the original press release on ACCESS Newswire
O.Johnson--AMWN
